View Older Stories
-
AmerisourceBergen (ABC) Announces Secondary Public Offering of Common Shares and Common Share Repurchase
-
AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
-
AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
-
AmerisourceBergen (ABC) Announces Acquisition of PharmaLex for EUR1.28B
-
AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
-
AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
-
AmerisourceBergen (ABC) Presents Long-term Vision and Guidance at Investor Day
-
AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
-
AmerisourceBergen (ABC) reiterates fiscal year 2022 guidance
-
AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
-
AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
-
AmerisourceBergen Reports Fiscal 2022 First Quarter Results
-
AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
-
AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
-
New York Attorney General James Reaches $1.1 Billion Agreement with Big Three Distributors to Treat and Prevent Opioid Use in NYS
-
AmerisourceBergen (ABC) Completes Acquisition of Alliance Healthcare Businesses, Updates Guidance
-
AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
-
AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
-
AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031
-
AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
-
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
-
AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
-
AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results
-
McKesson says states seek $21 billion from drug distributors in opioid settlement
-
AmerisourceBergen Reports Fiscal 2020 Third Quarter Results
-
AmerisourceBergen Closes $500 Million Senior Note Offering
-
AmerisourceBergen Prices $500 Million 2.800% Senior Notes Due 2030
-
AmerisourceBergen Reports Fiscal 2020 Second Quarter Results
-
AmerisourceBergen Reports Fiscal 2020 First Quarter Results
-
AmerisourceBergen Reports Fiscal 2019 Fourth Quarter and Year End Results
-
Judge shields OxyContin-maker Purdue from litigation until April
-
Several states wary of $48 billion opioid settlement proposal
-
Opioid plaintiffs fight bid to disqualify U.S. judge before trial
-
AmerisourceBergen Reports Fiscal 2019 Third Quarter Results
-
AmerisourceBergen Reports Fiscal 2019 Second Quarter Results
-
AmerisourceBergen Reports Fiscal 2019 First Quarter Results
-
AmerisourceBergen Reports Fiscal 2018 Fourth Quarter and Year End Results
-
AmerisourceBergen (ABC) CFO Tim G. Guttman to Retire; to be Succeeded by James F. Cleary, Jr
-
AmerisourceBergen Announces Financial Leadership Change
-
AmerisourceBergen Reports Fiscal 2018 Third Quarter Results
-
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2018 Earnings Release
-
AmerisourceBergen Reports Fiscal 2018 Second Quarter Results
-
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2018 Earnings Release
-
AmerisourceBergen Declares Quarterly Dividend
-
AmerisourceBergen Reports Fiscal 2018 First Quarter Results
-
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2018 Earnings Release
-
AmerisourceBergen Completes Acquisition of H. D. Smith
-
AmerisourceBergen Closes $1.25 Billion Senior Note Offering
-
AmerisourceBergen Prices $750 Million 3.45% Senior Notes Due 2027 and $500 Million 4.30% Senior Notes Due 2047
-
AmerisourceBergen (ABC) to Acquire H. D. Smith for $815 Million in Cash

